Published May 2009
| Version v1
Journal article
Interest of a treatment combined by radioimmunotherapy and Avastin 1 in a murine model of thyroid medullary carcinoma
Creators
- 1. Unite Inserm U892, Brest, (France)
Description
The objective of this study was to evaluate the efficiency and the toxicity of the association radioimmunotherapy and bevacizumab on a murine model grafted by the human line T.T. of thyroid medullar cancer. After results it appears that in pretreatment, bevacizumab (Avastin) improves the efficiency of radioimmunotherapy without increasing the toxicity face the radioimmunotherapy alone. (N.C.)
Availability note (English)
Available from doi:Additional details
Additional titles
- Original title (French)
- Interet d'un traitement combine par radioimmunotherapie et Avastin1 dans un modele murin de carcinome medullaire de la thyroide
Identifiers
Publishing Information
- Journal Title
- Medecine Nucleaire. Imagerie Fonctionnelle et Metabolique
- Journal Volume
- 33
- Journal Issue
- no.5
- Journal Page Range
- p. 233
- ISSN
- 0928-1258
- CODEN
- MNIMEX
INIS
- Country of Publication
- France
- Country of Input or Organization
- France
- INIS RN
- 40074057
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; COMBINED THERAPY; IODINE 131; NUCLEAR MEDICINE; RADIOIMMUNOTHERAPY; RATS; THYROID; TOXICITY
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE GLANDS; GLANDS; IMMUNOTHERAPY; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MAMMALS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; RODENTS; THERAPY; VERTEBRATES